Back to Search
ROBERT GELBER, MD
Internal Medicine Physician
NPI: 1801972765Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
G14127(CA)
Research & Publications (20)
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.
PMID 19633051·Ann Oncol·2010
4-observational
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.
PMID 19474112·Ann Oncol·2009
3-trial
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
PMID 18325918·Ann Oncol·2008
8-other
Measures of obesity and cardiovascular risk among men and women.
PMID 18702962·J Am Coll Cardiol·2008
2-rct
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer.
PMID 18385202·Ann Oncol·2008
2-rct
A prospective study of body mass index and the risk of developing hypertension in men.
PMID 17386342·Am J Hypertens·2007
8-other
Body mass index and mortality in men: evaluating the shape of the association.
PMID 17342077·Int J Obes (Lond)·2007
8-other
Ethnic disparities in breast cancer management among Asian Americans and Pacific Islanders.
PMID 16788760·Ann Surg Oncol·2006
4-observational
Tailoring adjuvant treatments for the individual breast cancer patient.
PMID 14659135·Breast·2003
6-review
Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.
PMID 19280340·Breast Cancer Res Treat·2010
4-observational
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.
PMID 19468030·Ann Oncol·2009
4-observational
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy.
PMID 18941889·Breast Cancer Res Treat·2009
3-trial
Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancer.
PMID 19243946·Breast·2009
2-rct
Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial.
PMID 19364966·J Clin Oncol·2009
3-trial
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93.
PMID 18259856·Breast Cancer Res Treat·2009
4-observational
Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.
PMID 19062268·Eur J Cancer·2009
3-trial
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.
PMID 18953651·Breast Cancer Res Treat·2009
4-observational
Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century.
PMID 19137426·Breast Cancer Res Treat·2009
8-other
A small sample study of the STEPP approach to assessing treatment-covariate interactions in survival data.
PMID 19170050·Stat Med·2009
8-other
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
PMID 19484813·N Engl J Med·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3260 KERNER BLVD
SAN RAFAEL, CA 94901 - Phone
- (415) 473-6890
Quick Facts
- NPI
- 1801972765
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile